相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Human CYP1A1 inhibition by flavonoids
Rebeca Santes-Palacios et al.
TOXICOLOGY IN VITRO (2020)
SuperCYPsPred-a web server for the prediction of cytochrome activity
Priyanka Banerjee et al.
NUCLEIC ACIDS RESEARCH (2020)
Four Major Channels Detected in the Cytochrome P450 3A4: A Step toward Understanding Its Multispecificity
Lydia Benkaidali et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Prediction of Human Cytochrome P450 Inhibition Using a Multitask Deep Autoencoder Neural Network
Xiang Li et al.
MOLECULAR PHARMACEUTICS (2018)
Screening of cytochrome P450 3A4 inhibitors via in silico and in vitro approaches
Xiaocong Pang et al.
RSC ADVANCES (2018)
An improved substrate cocktail for assessing direct inhibition and time-dependent inhibition of multiple cytochrome P450s
Zhong-hua Chen et al.
ACTA PHARMACOLOGICA SINICA (2016)
Inhibition of cytochrome P450 3A by acetoxylated analogues of resveratrol in in vitro and in silico models
Loai Basheer et al.
SCIENTIFIC REPORTS (2016)
PLIP: fully automated protein-ligand interaction profiler
Sebastian Salentin et al.
NUCLEIC ACIDS RESEARCH (2015)
Cytochrome P450 Family 1 Inhibitors and Structure-Activity Relationships
Jiawang Liu et al.
MOLECULES (2013)
Production, Characterization, and Antioxidant Activity of Fucoxanthin from the Marine Diatom Odontella aurita
Song Xia et al.
MARINE DRUGS (2013)
Human cytochromes P450 in health and disease
Daniel W. Nebert et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2013)
Inhibition of the enzyme activity of cytochrome P450 1A1, 1A2 and 3A4 by fucoxanthin, a marine carotenoid
Yoshiko Satomi et al.
ONCOLOGY LETTERS (2013)
Fucoxanthin Attenuates Rifampin-Induced Cytochrome P450 3A4 (CYP3A4) and Multiple Drug Resistance 1 (MDR1) Gene Expression Through Pregnane X Receptor (PXR)-Mediated Pathways in Human Hepatoma HepG2 and Colon Adenocarcinoma LS174T Cells
Cheng-Ling Liu et al.
MARINE DRUGS (2012)
Astaxanthin can alter CYP1A-dependent activities via two different mechanisms: Induction of protein expression and inhibition of NADPH P450 reductase dependent electron transfer
Marumi Ohno et al.
FOOD AND CHEMICAL TOXICOLOGY (2011)
Open Babel: An open chemical toolbox
Noel M. O'Boyle et al.
JOURNAL OF CHEMINFORMATICS (2011)
Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading
Oleg Trott et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
The carotenoid lycopene differentially regulates phase I and II enzymes in dimethylbenz[a]anthracene-induced MCF-7 cells
Huan Wang et al.
NUTRITION (2010)
Anti-angiogenic effect of siphonaxanthin from green alga, Codium fragile
Ponesakki Ganesan et al.
PHYTOMEDICINE (2010)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Cytochrome P450 and chemical toxicology
F. Peter Guengerich
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Commercial-scale Preparation of Biofunctional Fucoxanthin from Waste Parts of Brown Sea Algae Laminalia japonica
Kazuki Kanazawa et al.
FOOD SCIENCE AND TECHNOLOGY RESEARCH (2008)
Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2
Stefaan Sansen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The ins and outs of cytochrome P450s
Vlad Cojocaru et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2007)
Xenobiotic-metabolizing enzymes in human lung
Ji Y. Zhang et al.
CURRENT DRUG METABOLISM (2006)
Structural basis for ligand promiscuity in cytochrome P450 3A4
Marika Ekroos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons
Tsutomu Shimada
DRUG METABOLISM AND PHARMACOKINETICS (2006)
Predicting in vivo drug interactions from in vitro drug discovery data
LC Wienkers et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
The conduct of in vitro and in vivo drug-drug interaction studies: A Pharmaceutical Research and Manufacturers of America (PhRMA) perspective
TD Bjornsson et al.
DRUG METABOLISM AND DISPOSITION (2003)
Roles of human liver cytochrome P450 3A4 and 1A2 enzymes in the oxidation of myristicin
CH Yun et al.
TOXICOLOGY LETTERS (2003)
Timing of new black box warnings and withdrawals for prescription medications
KE Lasser et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions
W Tang et al.
CURRENT DRUG METABOLISM (2001)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
分享论文
